CN Patent

CN104892609B — 一种利拉利汀中间体及其制备方法和应用

Assigned to XINXIANG HAIBIN PHARMACEUTICAL CO Ltd · Expires 2017-06-20 · 9y expired

What this patent protects

本发明涉及一种利拉利汀中间体及其制备方法和应用。本发明的利拉利汀中间体具有通式(II)和式(IV)所示的结构： 其中，X为卤素。本发明化合物为固体，制备成本低廉，易于纯化和保存，可高效制备得到利拉列汀，更加适合于工业化规模生产。

USPTO Abstract

本发明涉及一种利拉利汀中间体及其制备方法和应用。本发明的利拉利汀中间体具有通式(II)和式(IV)所示的结构： 其中，X为卤素。本发明化合物为固体，制备成本低廉，易于纯化和保存，可高效制备得到利拉列汀，更加适合于工业化规模生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN104892609B
Jurisdiction
CN
Classification
—
Expires
2017-06-20
Drug substance claim
No
Drug product claim
No
Assignee
XINXIANG HAIBIN PHARMACEUTICAL CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.